Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):339–346. doi: 10.1097/QAI.0000000000001822

Table 3.

Sex behavior, substance use, and STI variables by PrEP use among BMSM (N=4,184) from multiple US cities.

Current PrEP User
No (N=3,804) Yes (N=380)
Variable M SD M SD aOR (95%CI)
Sex Behavior (past 12 months)
Number of male anal sex partners 3.77 6.52 6.48 11.03 1.04 (1.03–1.05)***
Number of partners receptive anal sex 1.78 3.56 2.81 5.39 1.05 (1.03–1.07)***
Number of partners insertive anal sex 2.50 4.74 4.04 6.78 1.05 (1.03–1.06)***
N % N %
Condom use during receptive anal sex
 Always/mostly
 Sometimes/never
2856
946
75.1
24.9
240
140
63.2
36.8

.60 (.48–.75)***
Condom use during insertive anal sex
 Always/mostly
 Sometimes/never
2823
981
74.2
25.8
250
130
65.8
34.2

.71 (.57–.89)***
Received goods for sex with male partner 196 5.2 32 8.4 1.65 (1.10–2.45)
Drug use (past 3 months)
Marijuana 836 22.1 113 29.8 1.48 (1.16–1.87)**
Amyl nitrates 154 4.1 49 13.0 3.79 (2.67–5.36)***
Stimulants (crack, cocaine, meth, ecstasy) 215 5.7 60 15.8 3.58 (2.60–4.92)***
Erectile dysfunction medications 77 2.0 32 8.4 4.99 (3.22–7.75)***
Heroin 50 1.3 24 6.3 5.57 (3.34–9.29)***
Opiates 83 2.2 28 7.4 4.14 (2.62–6.52)***
Alcohol Use
Problematic alcohol use (CAGE ≥2) 699 18.4 120 31.6 2.11 (1.66–2.67)***
Heavy Episodic Drinking (12 months) 2067 54.5 194 51.1 0.91 (.74–1.13)
STI (past 12 months) N % N %
Gonorrhea 345 9.1 138 36.3 5.66 (4.45–7.20)***
Chlamydia 246 6.5 121 31.8 6.90 (5.33–8.92)***
Syphilis 189 5.0 97 25.5 6.42 (4.86–8.49)***
Other STI 159 4.2 88 23.2 7.13 (5.32–9.57)***
a

Note: All analyses controlled for city and year of assessment.